Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership

Frederick S. Nolte, N. Esther Babady, Blake W. Buchan, Gerald A. Capraro, Erin H. Graf, Amy L. Leber, Erin McElvania, Joseph D.C. Yao

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Clinical molecular laboratory professionals are at the frontline of the response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, providing accurate, high-quality laboratory results to aid in diagnosis, treatment, and epidemiology. In this role, we have encountered numerous regulatory, reimbursement, supply-chain, logistical, and systems challenges that we have struggled to overcome to fulfill our calling to provide patient care. In this Perspective from the Association for Molecular Pathology Infectious Disease Subdivision Leadership team, we review how our members have risen to these challenges, provide recommendations for managing the current pandemic, and outline the steps we can take as a community to better prepare for future pandemics.

Original languageEnglish (US)
Pages (from-to)968-974
Number of pages7
JournalJournal of Molecular Diagnostics
Volume22
Issue number8
DOIs
StatePublished - Aug 2020

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership'. Together they form a unique fingerprint.

Cite this